-Prostaglandin J2 (15d-PGJ2) Signals Through Retinoic Acid Receptor–Related Orphan Receptor- but Not Peroxisome Proliferator–Activated Receptor- in Human Vascular Endothelial Cells The Effect of 15d-PGJ2 on Tumor Necrosis Factor- –Induced Gene Expression
نویسندگان
چکیده
Induced Gene Expression − α Human Vascular Endothelial Cells : The Effect of 15d-PGJ2 on Tumor Necrosis Factorin γ Activated Receptor− but Not Peroxisome Proliferator α Related Orphan Receptor− (15d-PGJ2) Signals Through Retinoic Acid Receptor 2 -Prostaglandin J 12,14 ∆ 15-DeoxyPrint ISSN: 1079-5642. Online ISSN: 1524-4636 Copyright © 2005 American Heart Association, Inc. All rights reserved. Greenville Avenue, Dallas, TX 75231 is published by the American Heart Association, 7272 Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/01.ATV.0000156482.76228.d1 2005;25:710-716; originally published online January 20, 2005; Arterioscler Thromb Vasc Biol. http://atvb.ahajournals.org/content/25/4/710 World Wide Web at: The online version of this article, along with updated information and services, is located on the
منابع مشابه
15-Deoxy-Δ12,14-Prostaglandin J2 Protects PC12 cells from LPS-Induced Cell Death Through Nrf2 pathway in PPAR-γ Dependent Manner
Introduction: The inflammatory response requires a coordinated integration of various signaling pathway including cyclooxygenase (COX). COX catalyzes the formation of prostaglandins from arachidonic acid. Among prostaglandins, 15-Deoxy-D12, 14-prostaglandin J2 (15d-PGJ2), an endogenous ligand of Peroxisome proliferator-activated receptor-gamma (PPAR-γ), has been demonstrated to have anti-inflam...
متن کاملPeroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells.
OBJECTIVE Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reduce lesion formation in animal models of atherosclerosis by mechanisms that have not been defined completely. We hypothesized that PPARgamma ligands stimulate endothelial-derived nitric oxide release (*NO) to protect the vascular wall. METHODS AND RESULTS The PPARgamma ligands, 15-deoxy-Delta(12,14)-prostaglandi...
متن کامل15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
OBJECTIVE Brain expresses abundant lipocalin-type prostaglandin (PG) D2 (PGD2) synthase but the role of PGD2 and its metabolite, 15-deoxy-Delta(12,14) PGJ2 (15d-PGJ2) in brain protection is unclear. The aim of this study is to assess the effect of 15d-PGJ2 on neuroprotection. METHODS AND RESULTS Adenoviral transfer of cyclooxygenase-1 (Adv-COX-1) was used to amplify the production of 15d-PGJ2...
متن کامل15-Deoxy-#-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPAR; and potentiates TRAIL-induced apoptosis
15-Deoxy-#-prostaglandin J2 (15d-PGJ2), the terminal derivative of the PGJ series, is emerging as a potent antineoplastic agent among cyclopentenone prostaglandins derivatives and also known as the endogenous ligand of peroxisome proliferator-activated receptor ; (PPAR;). On the other hand, death receptor 5 (DR5) is a specific receptor for tumor necrosis factor–related apoptosisinducing ligand ...
متن کاملPeroxisome Proliferator-Activated Receptor Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-Activated Receptor –Dependent Mechanisms
Objective—We recently reported that the peroxisome proliferator-activated receptor (PPAR ) ligands 15-deoxyprostaglandin J2 (15d-PGJ2) and ciglitazone increased cultured endothelial cell nitric oxide (NO) release without increasing the expression of endothelial nitric oxide synthase (eNOS). The current study was designed to characterize further the molecular mechanisms underlying PPAR -ligand–s...
متن کامل